Macrophages phagocytose microorganisms and present antigens to T cells. Paradoxically, however, macrophages are also professional scavengers which normally phagocytose and present antigens derive from self proteins. The long-term goal of this project is to identify the mechanism by which macrophages inhibit autoimmune responses to these self antigens. The applications have identified a novel mechanism whereby macrophages may present antigens in an immunosuppressive, rather than immunostimulatory fashion. They show that macrophages that have differentiated under the influence of macrophage colony-stimulating factor (MCSF) inhibit attempted T cell activation. The mechanism of this inhibition is massive induction of the enzyme indoleamine 2, 3- dioxygenase (IDO), which selectively degrades the essential amino acid tryptophan. Simultaneously, MCSF-derived macrophages markedly increase trypthphan uptake via induction of a novel high-affinity, tryptophan- selective transport pathway. The applicants hypothesize that the combination of these two mechanisms allows macrophages to rapidly deplete tryptophan from the local microenvironment, thus aborting normal T cell activation. Consistent with the proposed role of IDO in suppresssing T cells, the applicants show that pharmacologic inhibition of IDO in vivo results in enhanced activation of autoreactive T cells, and that inhibition of IDO activity in placenta results in rapid, uniform, T cell-mediated rejection of all allogeneic fetuses.
The aims of the current proposal are to: (1) test the hypothesis that a synergistic combination of IFNgamma and CD40-ligand expression by T cells triggers IDO expression in macrophages, and characterize the effect of the resulting tryptophan depletion on T cell activation; (2) use a transgenic mouse model to test the hypothesis that IDO-expressing macrophages inhibit autoreactive T cell activation in vivo; and (3) define the functional characteristics and regulation of the high- affinity tryptophan transport system. These studies will define a fundamental and previously unsuspected mechanism of T cell regulation imposed by cells of the innate immune system.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL060137-03
Application #
6343616
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Thomas, John
Project Start
1999-01-01
Project End
2002-12-31
Budget Start
2001-01-01
Budget End
2001-12-31
Support Year
3
Fiscal Year
2001
Total Cost
$259,508
Indirect Cost
Name
Medical College of Georgia (MCG)
Department
Pediatrics
Type
Schools of Medicine
DUNS #
City
Augusta
State
GA
Country
United States
Zip Code
30912
Seymour, Robert L; Ganapathy, Vadivel; Mellor, Andrew L et al. (2006) A high-affinity, tryptophan-selective amino acid transport system in human macrophages. J Leukoc Biol 80:1320-7
Munn, David H; Sharma, Madhav D; Mellor, Andrew L (2004) Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J Immunol 172:4100-10
Lee, Jeffrey R; Dalton, Rory R; Messina, Jane L et al. (2003) Pattern of recruitment of immunoregulatory antigen-presenting cells in malignant melanoma. Lab Invest 83:1457-66
Mellor, Andrew L; Baban, Babak; Chandler, Phillip et al. (2003) Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J Immunol 171:1652-5
Mellor, Andrew L; Keskin, Derin B; Johnson, Theodore et al. (2002) Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses. J Immunol 168:3771-6
Lee, Geon Kook; Park, Hyeon Jin; Macleod, Megan et al. (2002) Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division. Immunology 107:452-60
Munn, David H; Sharma, Madhav D; Lee, Jeffrey R et al. (2002) Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297:1867-70
Mellor, A L; Munn, D H (2001) Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses. J Reprod Immunol 52:5-13
Mellor, A L; Sivakumar, J; Chandler, P et al. (2001) Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2:64-8
Horuzsko, A; Lenfant, F; Munn, D H et al. (2001) Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice. Int Immunol 13:385-94

Showing the most recent 10 out of 12 publications